featured
COVID-19 Vaccine Effectively Protects Inflammatory Bowel Disease Patients Without Exacerbating the Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
COVID-19 vaccine is effective in inflammatory bowel disease patients and is not associated with disease exacerbation
Clin. Gastroenterol. Hepatol. 2021 Dec 23;[EPub Ahead of Print], R Lev-Tzion, G Focht, R Lujan, A Mendelovici, C Friss, S Greenfeld, R Kariv, A Ben-Tov, E Matz, D Nevo, Y Barak-Corren, I Dotan, D TurnerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.